NeuroTalk Support Groups - AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS)

NeuroTalk Support Groups (https://www.neurotalk.org/)

- ALS News & Research (https://www.neurotalk.org/als-news-and-research/)

- - AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) (https://www.neurotalk.org/als-news-and-research/247196-ab-science-phase-3-data-masitinib-amyotrophic-lateral-sclerosis-als.html)

MuonOne

05-19-2017 01:23 PM

AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS)

AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting

Study was a success showing masitinib to be a safe and effective treatment in ALS

AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting Paris Stock Exchange:AB.PA

All times are GMT -5. The time now is 09:09 AM.